BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp decreased its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 40.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 163,405 shares of the company’s stock after selling 109,935 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp owned about 0.05% of Cardinal Health worth $10,935,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Bronfman E.L. Rothschild L.P. increased its position in shares of Cardinal Health by 31.8% during the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,583 shares of the company’s stock worth $123,000 after buying an additional 382 shares during the period. Advisory Services Network LLC increased its position in shares of Cardinal Health by 18.4% during the second quarter. Advisory Services Network LLC now owns 1,739 shares of the company’s stock worth $136,000 after buying an additional 270 shares during the period. Dupont Capital Management Corp acquired a new stake in shares of Cardinal Health during the second quarter worth $164,000. First Personal Financial Services increased its position in shares of Cardinal Health by 127.5% during the second quarter. First Personal Financial Services now owns 2,209 shares of the company’s stock worth $172,000 after buying an additional 1,238 shares during the period. Finally, Sun Life Financial INC increased its position in shares of Cardinal Health by 16,228.6% during the second quarter. Sun Life Financial INC now owns 2,286 shares of the company’s stock worth $178,000 after buying an additional 2,272 shares during the period. Institutional investors and hedge funds own 88.47% of the company’s stock.

Shares of Cardinal Health, Inc. (NYSE CAH) opened at $58.89 on Friday. Cardinal Health, Inc. has a 12-month low of $54.66 and a 12-month high of $84.88. The company has a debt-to-equity ratio of 1.35, a current ratio of 1.06 and a quick ratio of 0.52. The stock has a market cap of $18,527.03, a P/E ratio of 11.17, a PEG ratio of 1.70 and a beta of 0.85.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Monday, November 6th. The company reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.00 by $0.09. The company had revenue of $32.64 billion for the quarter, compared to analyst estimates of $33.48 billion. Cardinal Health had a net margin of 0.84% and a return on equity of 25.24%. The company’s quarterly revenue was up 1.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.24 earnings per share. sell-side analysts expect that Cardinal Health, Inc. will post 4.97 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Tuesday, January 2nd will be paid a dividend of $0.4624 per share. The ex-dividend date of this dividend is Friday, December 29th. This represents a $1.85 annualized dividend and a yield of 3.14%. Cardinal Health’s dividend payout ratio is currently 53.78%.

A number of equities research analysts have commented on the stock. Needham & Company LLC restated a “hold” rating on shares of Cardinal Health in a report on Sunday, September 10th. Jefferies Group set a $77.00 price objective on shares of Cardinal Health and gave the company a “hold” rating in a report on Tuesday, August 29th. Cowen upgraded shares of Cardinal Health to a “buy” rating and set a $74.00 price objective for the company in a report on Tuesday, October 10th. Mizuho set a $70.00 price objective on shares of Cardinal Health and gave the company a “hold” rating in a report on Tuesday, October 24th. Finally, Robert W. Baird reiterated a “hold” rating and set a $73.00 price objective on shares of Cardinal Health in a report on Sunday, September 17th. Two equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating and five have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $73.91.

TRADEMARK VIOLATION WARNING: “BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Has $10.94 Million Position in Cardinal Health, Inc. (CAH)” was published by Watch List News and is owned by of Watch List News. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international trademark and copyright law. The original version of this piece of content can be read at https://www.watchlistnews.com/british-columbia-investment-management-corp-has-10-94-million-position-in-cardinal-health-inc-cah/1755623.html.

Cardinal Health Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.